ALEGRET-MOLINA; Carlos

Patent Applications and Registrations

Patent applications and USPTO patent grants for ALEGRET-MOLINA; Carlos.The latest application filed is for "oxadiazaspiro compounds for the treatment of drug abuse and addiction".

Company Profile

6.8.11

ALEGRET-MOLINA; Carlos - Barcelona ES
Alegret-Molina; Carlos - Barcelone ES

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oxadiazaspiro Compounds For The Treatment Of Drug Abuse And Addiction App 20210115062 - VIRGILI-BERNADO; Marina ; et al.	2021-04-22
Oxadiazaspiro compounds for the treatment of drug abuse and addiction Grant 10,927,128 - Virgili-Bernado , et al. February 23, 2	2021-02-23
Alkyl And Aryl Derivatives Of 1-oxa-4,9-diazaspiro Undecane Compounds Having Multimodal Activity Against Pain App 20200339597 - Virgili-Bernado; Marina ; et al.	2020-10-29
Alkyl and aryl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain Grant 10,703,765 - Virgili-Bernado , et al.	2020-07-07
OXA-Diazaspiro compounds having activity against pain Grant 10,689,398 - Virgili-Bernado , et al.	2020-06-23
Substituted morpholine derivatives having activity against pain Grant 10,421,750 - Virgili-Bernado , et al. Sept	2019-09-24
Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain App 20190177337 - VIRGILI-BERNADO; Marina ; et al.	2019-06-13
Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain Grant 10,246,465 - Virgili-Bernado , et al.	2019-04-02
Oxa-azaspiro compounds having activity against pain Grant 10,183,918 - Almansa-Rosales , et al. Ja	2019-01-22
Oxa-diazaspiro Compounds Having Activity Against Pain App 20190002475 - VIRGILI-BERNADO; Marina ; et al.	2019-01-03
Oxadiazaspiro Compounds For The Treatment Of Drug Abuse And Addiction App 20180327422 - VIRGILI-BERNADO; Marina ; et al.	2018-11-15
Oxa-azaspiro Compounds Having Activity Against Pain App 20180312479 - ALMANSA-ROSALES; Carmen ; et al.	2018-11-01
Substituted Morpholine Derivatives Having Activity Against Pain App 20180305343 - VIRGILI-BERNADO; Marina ; et al.	2018-10-25
Amide derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain Grant 10,065,971 - Virgili-Bernado , et al. September 4, 2	2018-09-04
1,9-diazaspiro undecane compounds having multimodal activity against pain Grant 10,022,359 - Virgili-Bernado , et al. July 17, 2	2018-07-17
1,9-diazaspiro Undecane Compounds Having Multimodal Activity Against Pain App 20170354648 - VIRGILI-BERNADO; Marina ; et al.	2017-12-14
Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain App 20170313723 - VIRGILI-BERNADO; Marina ; et al.	2017-11-02
Amide Derivatives Of 1-oxa-4,9-diazaspiro Undecane Compounds Having Multimodal Activity Against Pain App 20170197984 - VIRGILI-BERNADO; Marina ; et al.	2017-07-13
Alkyl And Aryl Derivatives Of 1-oxa-4,9-diazaspiro Undecane Compounds Having Multimodal Activity Against Pain App 20170101420 - VIRGILI-BERNADO; Marina ; et al.	2017-04-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.